相关实验视频
Updated: Apr 2, 2026

06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
23.1K
在帕金森病下方的乘法信息LRRK
1Department of Neurology, Department of Cell and Developmental Biology, University of Michigan Medical School, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA.
Cell
|April 15, 2014
概括
研究人员将帕金森病蛋白LRRK2与翻译控制中的问题联系起来. 这一发现为神经退行性疾病和正常衰老过程提供了新的见解.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病.
- 目前PD的治疗选择有限.
- LRRK2是一种关键蛋白质,与PD病变发生有关.
研究的目的:
- 研究白丰富的重复激酶2 (LRRK2) 在帕金森病中的作用.
- 探索LRRK2与翻译控制机制之间的联系.
- 了解这些发现对中枢神经系统神经退行性疾病和衰老的影响.
主要方法:
- 马丁等人进行的研究. 它将LRRK2与翻译控制中的异常联系起来.
- 这项研究涉及神经退行的一个特定的致病机制.
主要成果:
- LRRK2与调节蛋白质合成 (翻译控制) 的干扰直接相关.
- 这种机制在各种中枢神经系统 (CNS) 神经退行性疾病中越来越被认可.
- 这些发现还表明它在正常的衰老过程中发挥了作用.
结论:
- 翻译控制中的异常,由LRRK2介导,代表了帕金森病的显著致病机制.
- 这一发现扩大了我们对PD及其与其他神经退行性疾病的关系的理解.
- 该研究强调了与PD和衰老的转化控制相关的潜在治疗目标.
更多相关视频
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
16.3K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
8.1K
相关概念视频
Neural Regulation
44.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.9K
Lysosomal Hydrolases
4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K